GLENMEDE TRUST CO NA - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$73,000
+9.0%
3,162
-4.3%
0.00%
Q1 2018$67,0000.0%3,3050.0%0.00%
Q4 2017$67,000
+39.6%
3,305
-4.6%
0.00%
Q3 2017$48,000
+9.1%
3,466
-14.9%
0.00%
Q2 2017$44,0000.0%4,0750.0%0.00%
Q1 2017$44,000
-12.0%
4,075
+16.6%
0.00%
Q4 2016$50,000
-43.2%
3,495
-3.4%
0.00%
Q3 2016$88,000
+23.9%
3,619
+0.9%
0.00%
Q2 2016$71,000
+36.5%
3,585
+80.0%
0.00%
Q1 2016$52,000
-79.3%
1,992
-19.4%
0.00%
-100.0%
Q4 2015$251,000
-49.0%
2,472
-10.4%
0.00%
-50.0%
Q3 2015$492,000
-17.9%
2,759
+2.0%
0.00%0.0%
Q2 2015$599,000
+37.4%
2,704
+22.9%
0.00%
+33.3%
Q1 2015$436,000
+55.2%
2,200
+11.6%
0.00%
+50.0%
Q4 2014$281,000
-10.8%
1,971
-18.3%
0.00%
-33.3%
Q3 2014$315,000
-26.2%
2,412
-29.0%
0.00%
-25.0%
Q2 2014$427,000
+7.0%
3,395
+12.0%
0.00%0.0%
Q1 2014$399,000
-5.5%
3,030
-15.9%
0.00%0.0%
Q4 2013$422,000
-45.5%
3,604
-51.5%
0.00%
-55.6%
Q3 2013$774,000
+27.1%
7,429
+4.9%
0.01%
+12.5%
Q2 2013$609,0007,0840.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2018
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,586,582$864,160,00032.02%
FARLEY CAPITAL L.P. 341,518$44,807,00030.12%
LeVasseur Capital Partners LLC 190,404$24,981,00029.94%
Ruane, Cunniff & Goldfarb 34,494,015$4,525,615,00023.97%
ValueAct Holdings 18,923,877$2,482,813,00016.64%
White River Investment Partners, LLC 90,099$11,820,00016.35%
Tesuji Partners 1,368,040$179,487,00015.45%
Arrow Capital Management, LLC 197,500$25,912,00015.11%
Hound Partners 3,576,998$469,302,00014.87%
Brahman Capital Corp. 4,457,153$584,778,00012.82%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders